The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15503
StudyName: Eligibility Metastatic HER2-Positive Breast Cancer NCT02252887
Date of export from the portal: 02.07.2020
Date of Upload / last change: 01.06.2016
License: Creative Commons BY 4.0

----

Description: 
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT02252887
